Merck to Bristol-Myers Face More Threats on India Patents

... The country has an estimated 2.1 million people living with HIV, according to the Joint United Nations Programme on HIV/AIDS. The committee recommended compulsory licensing for dasatinib, a Bristol-Myers therapy for chronic myeloid leukemia sold ...

http://ift.tt/KD1Bsh